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Abstract
In this chapter a description is explained about radiotherapy as common available method 
in treatment of thoracic tumors located at thorax region of patient body and move mainly 
due to respiration. In radiotherapy of dynamic tumors, the correct and accurate informa-
tion of tumor position during the therapeutic irradiation determine the degree of treat-
ment success. In this chapter we investigate quantitatively the effect of tumor motion on 
treatment quality by considering to possible drawbacks and errors at external surrogate’s 
radiotherapy as clinical treatment modality. For this aim, tumor motion information of 
a group of real patients treated with Cybeknife Synchrony system (from Georgetown 
University Hospital) was taken into account. A fuzzy logic based correlation model was 
employed for tumor motion tracking. Final results represent graphically the amount of 
tumor motion estimated by our utilized correlation model on three dimensions with tar-
geting error calculation. It’s worth mentioning that each strategy that can improve tar-
geting accuracy of dynamic tumors may strongly enhance treatment quality by saving 
healthy tissues against additional high dose. In this chapter we just tried to introduce 
readers with thoracic tumor motion error as challenging issue in radiotherapy and motion 
compensation solutions, implemented clinically up to now.
Keywords: radiotherapy, moving thoracic tumors, external surrogate’s radiotherapy, 
correlation model, motion compensation
1. Introduction
Cancer is a range of diseases including abnormal cells that grow out of control. Cancerous 
cells can be formed in the tissues or organs of patient body, and the damaged cells can invade 
surrounding tissues. Among different types of cancers, some of them that are known as most 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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common cancers such as lung, breast, and prostate cancers cause many deaths independent 
of human race or ethnicity. It should be noted that with early detection and treatment, most 
people continue a normal life [1, 2] .
There are three common available methods for treatment of different cancers known as surgery, 
chemotherapy, and radiotherapy alone or in combination mode as surgery-chemotherapy, 
surgery-radiotherapy, chemotherapy-radiotherapy, or surgery-chemotherapy-radiotherapy as 
the best treatment modality. Each treatment strategy depends on how the cancer is diagnosed 
and its stage. In clinical treatment, doctor will discuss with patients about which treatments 
are most suitable for them [1–7]. In the following, a description is explained about common 
treatment methods ranging from surgery to radiotherapy.
The first and oldest option of treatment modality for a variety range of cancers is surgery or 
operation that means to perform surgery. The type of surgery will depend on the type of each 
cancer. Surgery is usually followed by chemotherapy or radiotherapy in modern methods in 
order to enhance treatment quality. In this method, whole cancerous cells or lesion must be cut 
and removed. Moreover, surrounding cells around tumors that may potentially be cancerous 
cells are removed to avoid growing secondary tumors after operation. The tissue surrounding 
the tumor volume is called the margin. Removing this nearby margin depends directly on the 
medical doctor decision during surgery. All forms of surgery are considered as invasive proce-
dures. With conventional surgery, the surgeon makes large incisions through skin, muscle, and 
sometimes bone. In some situations, surgeons can use surgical techniques that are less inva-
sive. These less-invasive techniques may speed recovery and reduce pain afterward. At surgery 
strategy, in order to avoid growing secondary cancer, whole organ that include tumor cells are 
removed. For example, there are two main types of breast cancer surgery as: First mode, sur-
gery to remove the cancerous cells, entitled as breast-conserving surgery, where just the tumor 
and a little surrounding breast tissue are removed. Second mode, surgery to remove the whole 
breast, is called a mastectomy. However, in some cases, a mastectomy can be implemented by 
reconstructive surgery to recreate a bulge replacing the removed breast.
Chemotherapy involves using anti-cancer or cytotoxic medication to kill the cancer cells. 
Chemotherapy is usually given as an outpatient treatment, which means patients will not 
have to stay in hospital overnight. The medications are usually given through a drip straight 
into the blood through a vein. Chemotherapy is also usually used after surgery to destroy any 
cancer cells that have not been removed. This strategy is called as adjuvant chemotherapy. In 
some cases, chemotherapy is done before surgery, which is often used to shrink big tumors 
as much as possible. Several different medications are used for chemotherapy depending 
on tumor type and its site. For example, the choice of medication and the combination will 
depend on the type of breast cancer and how much it is spread [3, 6, 7]. Some patients may 
have chemotherapy sessions once every 2–3 weeks, over a period of 4–8 months, to give the 
body a rest in between treatments time. The main side effects of chemotherapy are caused by 
their influence on normal, healthy cells, such as immune cells.
Radiotherapy is the use of ionizing radiation beams such as high-energy X-rays or charge par-
ticles for cancer treatment. The therapeutic ionizing beam is generated by means of machines 
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called linear accelerator or cyclotron or synchrotron and can damage and destroy cancer cells 
within the area being irradiated. Radiotherapy is a very specialist treatment and is a common 
treatment for various ranges of cancer such as head and neck or thoracic tumors. In most 
cases, radiotherapy is given after surgery. This reduces the risk of cancer coming back by 
getting rid of any possible cancer cells that are still in the area. Figure 1 shows schematically 
the performance of linear machine as particle accelerator for therapeutic beam generation and 
irradiation to the patient [4, 5, 8].
Ionizing rays are able to produce biological damages physically and chemically. They release 
their energy by colliding with cells. This can produce fast-moving electrons, which ultimately 
produce the biological damage to tissues. As seen in Figure 2, the therapeutic beam can 
directly break the DNA known as physical effect or prepare a toxic environment around the 
cancerous cell for killing them known as chemical effect.
It should be noted that healthy tissues surrounding the tumor volume are affected by ionizing 
radiation, but their cells can usually recover themselves better than cancer cells implementing 
proper treatment planning strategies.
In radiotherapy, the main principle is delivering the maximum dose onto tumor volume while 
keeping the normal nearby tissues save against the high dose at the same time. Treatments are 
usually given regularly over a period of time so that they have the greatest effect on the cancer 
cells [5]. Radiotherapy can also be given implanting radioactive seeds into tumor volume. 
This is called internal radiotherapy or brachytherapy. By this strategy, the normal cells will be 
saved against additional dose that may have side effects. In this technique, tumor accessibility 
is very important to implant radioactive seeds. Therefore, intra-cavity tumors are subjects for 
brachytherapy.
Figure 1. A schematic layout of linear accelerator and the process of therapeutic beam generation.
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Figure 3 represents various steps of a successful radiotherapy based on 2D or 3D treatment 
planning system for tumor definition and localization. For this aim, tomography images are 
utilized as first step of treatment process. Simulation step realizes the best area to be irradi-
ated as target using high dose of irradiation while causing the fewest possible side effects 
considering critical organs or organs at risk (OAR). Moreover, patient positioning and verifi-
cation is another important issue of radiotherapy that must be carefully considered [4].
In general, total tumors can be categorized into two groups as static and dynamic tumors. This 
dividing comes from physical motion properties of tumors that is highly important during 
patient positioning and verification. In modern radiotherapy, tumor motion property is highly 
effective on treatment quality and must be taken into account during treatment planning pro-
cess. In radiotherapy of dynamic tumors, the correct and accurate information of tumor posi-
tion during the therapeutic irradiation determine the degree of treatment success. Among total 
tumors, dynamic tumors have been located in thorax and abdomen regions of patient body 
Figure 2. DNA damage of tumor cells by means of ionizing radiations.
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move due to breathing cycle phenomena, heart beat, and gastrointestinal system motions. 
The first case has the most important effect on targeting accuracy in radiation treatment. This 
motions and/or possible deformation that are usually nonregular cause a constraint to achieve 
the accurate knowledge of tumor location during the treatment process. This nonregular-
ity issue refers to variations on breathing motion amplitude and frequency, while these two 
parameters are highly variable at each time for each patient and therefore require caution at 
clinical settings. It is obvious that the parameters of breathing motion phenomena are different 
at each patient, and a sort of adaptive treatment planning must be depicted for each patient on a 
Figure 3. Block diagram of treatment process during radiotherapy.
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case by case basis, and this issue is problematic for operators and needs more accuracy at treat-
ment planning process. This motion error that is known as intra-fractional organs motion error 
may lead to a significant uncertainty of tumor localization. Therefore, a great amount of over or 
under dosage is happened onto tumor, and healthy surrounding tissues may receive high dose 
that is far away from prescribed dose that has been determined before irradiation [8–14]. Apart 
from intra-fraction motion error, we face with another motion error known as inter-fraction 
motion that refers to patient body displacement on treatment couch. This motion error must be 
considered at patient positioning stage during patient setup in pretreatment time few minutes 
before irradiation starting. Our focus in this chapter is on intra-fraction motion error.
At radiotherapy of dynamic tumors using old strategy, considerable margins were added 
around the planning target volume as treatment site to cover whole tumor displacement and 
possible deformation (known as internal target volume), and therefore, normal tissues sur-
rounding the target may irradiate unnecessarily. During the past decade, radiation treatment 
of moving tumors has been undergone major technological and methodological strategies. 
Such this development has been obtained by investments in research programs, computer 
development, and technology transfer from research to medicine, and generating of new 
generation therapy units dedicated on tumor motion tracking in real time. These assess-
ments were motivated by the requirements to enhance radiotherapy quality in patients with 
dynamic thoracic tumors such as those with lung, liver, or pancreas cancers. Several strategies 
have been proposed to compensate the effect of motion error on planned dose such as breath-
holding, respiratory motion-gating, and real-time tumor-tracking techniques [15–20].
In breath-holding technique, the goal is to immobilize the breast tumor by asking the patient 
to keep breathing in a specific level. Breath-holding technique requires cooperating patients 
that are problematic for patients with noncontrolled breathing [15, 17]. Respiratory-gated 
radiotherapy was proposed as another method to save normal surrounding tissue of dynamic 
region against additional high dose by irradiating the therapeutic beam only in a predefined 
phase of the breathing cycle [18, 19]. In real-time tumor-tracking technique, the irradiation 
beam is continuously repositioned dynamically to trace breast tumor motion in real time. In 
this method that is still under developing, the beam is always ON during a treatment fraction.
The developed technologies and methods for tumor tracking in X-ray radiotherapy can also be 
implemented for applications in hadron therapy using protons or heavier ions as therapeutic 
beams. Recent assessments show the using of particle therapy at worldwide in recent years, 
while 39 facilities were operational at the end of 2011, 33 with protons and six with carbon ions. 
Moreover, 20 new facilities are currently in the planning stage or under construction. As an 
example, hypo-fractionated particle therapy shows promising results in local control and overall 
survival in stage one of non–small lung cancer cells. Due to physical properties of charged par-
ticles, therapeutic beams can be steered by fast magnets to follow dynamic targets in real-time 
mode. Therefore, for treatment of moving tumors, charged particles such as protons and carbon 
ions have better geometrical and biological selectivity in regard with photon beam, and this use-
ful property can improve tumor tracking and localization at clinical applications. At particle ther-
apy, conventional dose delivery system is based on passive range modulation of the beam. Some 
scattering strategies are implemented to provide lateral beam flattering according to transverse 
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size of tumor volume. Moreover, some passive devices such as ridge filters are used to make 
spread out Bragg peak (SOBP) as responsible to flat the beam longitudinally in direction of beam 
propagation inside tumor volume. Thus, 3D uniform dose can be generated onto tumor volume 
simultaneously. In particle therapy, the treatment of dynamic tumors can be taken into account 
on the basis of passive modulation technique or wobbling magnets performance.
In order to implement respiratory gated and real-time tumor-tracking radiotherapy techniques 
that mentioned above, tumor position information must be extracted as function of time during 
treatment. These strategies make use of time-resolved 4D imaging systems during treatment 
planning process in combination with technologies of image guiding. This solution enhances 
targeting accuracy during irradiation. Moreover, in treatment planning by using 4D computed 
tomography, images can highly improve target and sensitive organs around the tumors can be 
saved against additional doses accordingly in comparison with conventional radiotherapy. In 
other word, enlargement of margins around the dynamic tumors is significantly reduced using 
new technology considering tumor motion tracking.
Based on above descriptions, tumor motion monitoring requires additional imaging hard 
wares at treatment room to represent inter and intra fraction motions for patient geometrical 
setup in pre-treatment and real-time tumor tracking during treatment, respectively. Among 
several monitoring methods, some of clinically available techniques range from continuous 
X-ray imaging (i.e., fluoroscopy) to the use of external surrogates radiotherapy [20–33]. In an 
ideal form, the tumor motion would be observed continuously using fluoroscopic imaging 
system at external beam radiotherapy. This aim can also be achieved using cone beam com-
puted tomography (CBCT) installed at radiotherapy treatment room. It is worth mentioning 
that with conventional megavoltage X-ray radiotherapy, inter-fraction daily variations can be 
obtained by time-resolved on-board images taken by CBCT that show respiratory-correlated 
tumor motion before treatment.
While tumor contrast is not proper during imaging of some organs by fluoroscopy or CBCT, 
a fiducial marker is implanted near or inside tumor volume representing a given point of 
that nonvisible tumor [8]. Therefore, internal clips represent tumor position with a 3D spatial 
point shown by x(t), y(t), and z(t) over treatment time.
During each irradiation fraction, implanted fiducial is traced by means of fluoroscopy imaging 
system, providing 3-dimensional (3D) coordinates at usually 30 frames per second. The tumor 
motion information is then utilized to turn the beam ON, while the tumor is in the desired 
place at radiotherapy based on respiratory motion-gated strategy. Apart from some advanta-
geous points of using fluoroscopy imaging, this method would deliver significant imaging 
dose mainly at hypo-fractionated radiotherapy and radiosurgery [8, 9]. Therefore, a trade off 
must be taken into account between additional imaging dose and motion monitoring accuracy. 
As solution, using external surrogate’s technique, the patient is kept away additional imaging 
dose versus fluoroscopy-based tumor motion monitoring.
At external surrogate’s radiotherapy, the external rib cage and abdomen skin motion is syn-
chronized and correlated with internal tumor motion by developing a proper correlation 
model in training step before the treatment. It should be mentioned that the external motion 
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is traced by means of specific external markers placed on thorax region (rib cage and abdo-
men) of patient body and recorded by some monitoring systems such as infrared optical 
tracking (OTS) or laser-based systems. In contrast, the internal tumor motion is tracked using 
implanted internal clips inside or near the tumor volume and is visualized using orthogonal 
X-ray imaging system in snapshot mode. The generated correlation model can estimate the 
tumor motion from external markers data as input when internal marker data are out of access. 
The end result is a nonlinear mapping from the motion data of external markers as input to 
an output, which is the estimate of tumor position versus time. Recently, several respiratory 
motion prediction models have been developed in different mathematical approaches [34–37]. 
Since the breathing phenomena have inherently high uncertainty and therefore cause a sig-
nificant variability in input/output data set, a mathematical model with highest accuracy may 
correlate input data with tumor motion estimation with less uncertainty error [8].
Since explaining all proposed strategies concerning tumor motion management is very exten-
sive, we concentrated on external surrogate’s radiotherapy in this chapter as clinical available 
strategy. Therefore, in this chapter, we quantitatively investigate the effect of motion error 
of thoracic tumors on treatment process at external surrogate’s radiotherapy. To do this, the 
motion information of a group of real patients treated with Cyberknife Synchrony system 
(from Georgetown University Hospital) was taken into account, and the amount of possible 
errors of target localization was calculated using available statistical metrics [15].
2. Material and methods
The database utilized in this chapter consists of 10 patients treated with real-time compensation 
of tumor motion by means of the Synchrony® respiratory tracking module, as available in the 
Cyberknife® system. This system provides tumor tracking relying on external/internal correla-
tion model between the motion of external infrared markers and of clips implanted near thoracic 
tumors. In this system, the correlation model will be constructed at the beginning of each treat-
ment session and will be updated over the course of treatment. Figure 4 depicts three-mentioned 
steps as model configuration, model performance, and model update during treatment. The 
model is built by means of training data set before starting the treatment. Training data include 
3D external markers motion as model input and internal implanted clip as model output. When 
the model is made, it can be applied to estimate tumor motion as a function of time during the 
treatment. The model can also be updated and re-built as needed during the treatment with 
X-ray imaging representing the internal marker location. For model performance, the only input 
data including external markers motion are given, and the output is tumor motion estimation. 
The utilized model in this flowchart is based on fuzzy logic inference system that is robust 
enough for tumor motion prediction based on our previous studies [34–38].
Markers motion data set represents the position information of each marker as function of 
time. This data set is saved in matrix form for model construction and performance. Figure 5 
shows a matrix with n rows and nine columns including x, y, and z of three utilized external 
markers located on rib cage and abdomen regions. For model construction and performance, 
the motion data set should be firstly clustered. Motion data set is firstly arranged at two input 
and output matrices.
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As mentioned before, the utilized correlation model is on the basis of fuzzy logic concept. In 
fuzzy logic, linguistic variables represent operating parameters to apply a more human-like 
way of thinking. Fuzzy logic works by means of if-then rule-based approach to solve a problem 
rather than attempting to model a system mathematically. Recently, the main features of fuzzy 
logic theory make it highly applicable in many systematic designs in order to obtain a better 
performance when data analysis is too complex or impractical for conventional mathematical 
models. Since breathing motion variability is remarkable, fuzzy logic-based correlation model 
may robust and can practically be applied on a real patient data set. In fuzzy logic-based systems, 
membership functions represent the magnitude of participation of each input, graphically. The 
proposed fuzzy correlation model involves data clustering for membership function generation, 
as inputs for fuzzy inference system section. Data clustering analysis is the organization of a col-
lection of data set into clusters based on similarity. In the implemented fuzzy logic algorithm, 
data from all three external markers arranged in an input matrix with nine columns, and data 
Figure 4. A block diagram of a correlation model including its construction, performance and update.
Figure 5. X, Y and Z motion direction of three external markers inside matrix with n rows and nine columns.
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from internal marker set in an output matrix with 1 column are clustered initially. Sugeno and 
Mamdani types of fuzzy inference systems configured by (1) data fuzzification, (2) if-then rules 
induction, (3) application of implication method, (4) output aggregation, and (5) defuzzification 
steps, utilized due to its specific effects on model performance. The proposed correlation model 
was developed in MatLab (The MathWorks Inc., Natick, MA) using the embedded toolboxes 
of fuzzy logic. Figure 6 shows nine data points (small spots) of motion data set of one external 
marker clustered at three groups (large spots). The cluster centers (large spots) were distributed 
as an available mathematical method that works on the basis of data points’ spatial distribution 
density. After data clustering, membership functions will be obtained using the information of 
clusters center. The mathematical information of these functions is used for defining the param-
eters of learning based inference system as correlation model.
For real-time tumor tracking, the correlation models should be executed without a signifi-
cant delay such that on-time compensation strategy should be applied against tumor motion. 
Therefore, the execute time of each correlation model that strongly depends on the utilized 
mathematical procedures should be taken into account for clinical application.
3. Results
In order to show quantitatively the challenging issues of targeting accuracy concerning tho-
racic tumor, its motion and correlation model output of one lung patient were shown graphi-
cally. Moreover, root means square error (RMSE) was utilized as mathematic tool, and the 
average of RMSE over total patients used in this work was reported. Table 1 illustrates the 
Figure 6. Nine data points (small spots) of motion data set of an external marker with three clusters (large spots).
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motion information of 3D external markers and implanted clip inside tumor volume for 10 
patients plus treatment time for each patient.
As seen in Table 1, tumors type include lung liver, pancreas, and chest wall. In this table, LLL, 
RLL, and RUL indicate left lower lung, right lower lung, and right upper lung, correspond-
ingly. The average 3D RMSE over this patient group is 0.99 mm.
Figure 7 shows tumor motion in anterior posterior (AP), superior inferior (SI), and left right 
(LR) directions obtained from stereoscopic X-ray imaging regarding with correlation model 
output for a lung cancer patient. As seen in this figure, remarkable error belongs to tumor 
motion tracking at SI direction versus two other directions while the minimum similarity was 
happened in this direction. At both SI and LR directions, minimum targeting error is happen-
ing at middle part of total treatment time.
Figure 8 shows the tumor motion tracking of one patient with liver cancer over few minutes of 
treatment time on anterior posterior (AP) directions. The stereoscopic X-ray imaging points indi-
cated by dark spots in these figures represent the exact position of tumor location at that time.
As seen in this figure, breathing condition is almost normal and tumor tracking is going well 
with least uncertainty error, and there is a close correlation among model output and real 
Tumor 
location
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
RLL LLL Pancreas Right 
hilum
LLL Chest 
wall
Liver RUL Left 
splenic 
bed
Left flank
Tumor motion 
on SI (mm)
31.1 11.6 15.8 18.2 23.8 2.6 18.7 4.0 2.0 3.0
Tumor motion 
on LR (mm)
5.0 6.1 15.9 12.4 3.1 3.2 3.3 1.8 3.5 2.2
Tumor motion 
on AP (mm)
3.8 10.2 12.0 7.7 1.8 7.7 7.8 6.4 4.3 2.4
External 
motion (mm)
3.4 4.4 3.3 1.4 2.7 1.9 5.5 5.8 6.0 1.6
Imaging 
points 
intervals (s), 
mean
66.9 81.7 55.8 73.7 65.1 63.6 64.5 97.6 81.7 58.1
Imaging 
points 
intervals (s), 
STD
33.1 32.1 33.0 38.2 32.0 31.7 29.1 44.1 32.8 26.0
Total 
treatment 
time (min)
78.0 68.1 90.1 61.4 68.3 59.4 41.9 70.0 61.3 69.7
Table 1. Motion features of tumors and external markers of selected patients with their treatment time.
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Figure 8. Motion prediction of a liver tumor by means of fuzzy-based correlation model over treatment time. Dark spots 
taken by stereoscopic system represent the exact position of the tumor.
Figure 7. Lung tumor motion in anterior posterior (AP), superior inferior (SI) and left right (LR) directions obtained from 
stereoscopic X-ray Imaging in comparison with correlation model output.
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position of tumor. For this patient, the calculated root mean square error (RMSE) is 1.7-mm 
3D that represents tumor motion tracking is performing as well by means of utilized fuzzy-
based prediction model. As noncontrol patient with large error, Figure 9 represents targeting 
error of one worse patient with pancreas cancer with abnormal breathing motion variation at 
LR direction. As seen in this figure, tumor motion tracking is with large error; while at some 
times, the distance between imaging data point and the output of correlation model is signifi-
cant. For example, third imaging point is far away from model output that represents motion 
tracking is not going well. This is nonnegligible targeting error that should be considered to 
be minimized.
4. Discussion
Cancer disease is one of the most common reasons of death at worldwide. A number of treat-
ments for cancer include surgery, chemotherapy, and radiotherapy. Radiation therapy is one 
of the most common treatments for some cancer cells. It uses X-rays, gamma rays, electron 
beams, or protons and heavy ions to physically and chemically damage DNA of cancer cells. 
Radiation can be given alone or used with other treatment modalities, such as surgery or 
chemotherapy. In principal, at radiation therapy, several strategies can be utilized to deliver 
high doses of radiation to the cancer cells as target while delivering minimum dose to the sur-
rounding healthy tissues at the same time. The goal of radiation treatment is to damage cancer 
cells, with as little harm as possible to nearby healthy cells. By the way, nearby normal cells 
may also be affected by radiation, but they will recover and go back to work normal. Unlike 
chemotherapy, which exposes the whole body to cancer-fighting drugs, in most cases, radia-
tion therapy is a local treatment.
Figure 9. Motion prediction of a pancreas tumor by means of fuzzy-based correlation model over treatment time. Dark 
spots taken by stereoscopic system represent the exact position of tumor.
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In this chapter, we focused on radiation treatment of moving thoracic tumors located in thorax 
region of patient body and move mainly due to respiration. This motion will be problematic 
for tumor localization and its aligning against therapeutic beam. In old strategies, tumor vol-
ume at its total moving space entitled internal tumor volume was considered as target for irra-
diation. In this strategy, a remarkable dose is received by nearby normal tissues that may cause 
serious side effects. Then, several efforts were done for tumor motion error compensation as 
motion-gated radiotherapy or real-time tumor-tracking radiotherapy. At both latter strate-
gies, tumor motion information should be extracted as a function of time during irradiation. 
In this chapter, we quantitatively assess the effect of tumor motion and possible drawbacks 
and errors at external surrogate’s radiotherapy. For this aim, tumor motion information of a 
real patient treated with Cyberknife Synchrony system was taken into account. A fuzzy logic-
based correlation model was developed to track tumor motion using motion data set of rib 
cage and abdomen region of patient. Final results represent graphically the amount of tumor 
motion estimated by utilized model on 3D with a calculated targeting error. In order to reduce 
such errors, more robust prediction models should be implemented. Moreover, the accuracy of 
model learning and its configuration at pretreatment step before therapeutic irradiation may 
reduce estimation error. At external beam radiotherapy of dynamic tumors, another issue that 
must be considered is due to patient displacement or inter-fractional motion error between 
each fractions of treatment process. In the modern radiotherapy, the success degree of a treat-
ment strongly depends on the compensation of both inter- and intra-fraction motion errors.
5. Conclusion
At modern radiotherapy, the main aim is enhancing treatment quality by maximizing tar-
get localization and dose delivery accuracy onto tumor volume while minimizing the dose 
received by normal nearby tissues. Reaching to this aim can be problematic and difficult for 
thoracic tumors where these tumors move mainly due to respiration. Therefore, while tumor 
motion is an issue, target localization cannot be done carefully and an over-under dose my 
deliver onto tumor volume that will not be the prescribed dose simulated at treatment plan-
ning process. In order to compensate the effect of tumor motion error during therapeutic 
beam irradiation, several strategies have been implemented or under developing. Three 
major strategies are as follow: breath-holding technique as old method, respiratory-gated 
radiotherapy as current clinical available method, and real-time tumor tracking radiother-
apy as under developing technique. In the latter case, the irradiation beam is continuously 
repositioned dynamically to trace breast tumor motion in real time. For both latter cases, 
the key component for reaching to our aim is to discover the information of tumor position 
versus time. To do this, some additional monitoring systems are required to track tumor 
motion as real time ranging from continuous X-ray imagers to the use of external markers 
or surrogates radiotherapy. In this chapter, we introduced readers with tumor motion as 
a challenging issue during radiotherapy and presenting external surrogates based radio-
therapy as clinical implemented method at several radiotherapy centers or hospitals in the 
worldwide. In this work, we utilized a typical fuzzy logic-based correlation model to predict 
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tumor motion due to the robustness and simplicity of this model that has been proved at 
our recent works. This method is still under assessment to minimize available uncertainty 
errors or to remove possible drawbacks. We had several comprehensive studies on different 
aspect of this strategy by introducing different prediction models for real-time tumor track-
ing, their mathematical structures, and the properties of motion data set as inputs of the 
prediction models [34–38].
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